Covid-19 - The Purbottar

05 Jul

ICMR Bolsters ‘mid-August’ Covid Vaccine

editor0 CommentsHealthCovid-19, ICMR, Vaccine

The Indian Council of Medical Research has shortlisted 12 institutes, including one from Odisha, for human clinical trial of the India’s first COVID-19 vaccine. ICMR has developed the indigenous BBV152 COVID vaccine in partnership with Bharat Biotech International Limited (BBIL). The apex body selected 12 institutes to fast track clinical trials of the vaccine which is one of the top priority projects monitored by the Central government. "The vaccine is derived from a strain of SARS-CoV-2 isolated by ICMR-National Institute of Virology, Pune. ICMR and BBIL are jointly working for the pre-clinical as well as clinical development of this vaccine," an official said.

23 Jun

COVID-19: Glenmark receives approval for Favipiravir

editor0 CommentsHealthCovid-19

In a landmark development for COVID-19 patients in India, Glenmark Pharmaceuticals today announced the launch of antiviral drug Favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients. Glenmark has received manufacturing and marketing approval from India’s drug regulator, making FabiFlu the first oral Favipiravir-approved medication in India for the treatment of COVID-19. Favipiravir is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19. The antiviral offers broad-spectrum RNA virus coverage with clinical improvement noted across age groups 20 to 90 years. Favipiravir can be used in COVID-19 patients with co-morbid…

17 Jun

Elderly people with diabetes are more vulnerable to COVID-19

editor0 CommentsHealthCovid-19

Kolkata, June 2020: In Kolkata, up to 12% of the population is known to have diabetes and the average level of HbA1C was as high as 8.07% during January to March 2020 according to a report by India Diabetes Care Index. These findings clearly indicate that people with diabetes should be more vigilant about their glucose level and take proper medication to manage their condition. The risk of Coronavirus among people with diabetes is up to 50% higher and they are more likely to experience severe symptoms and complications when diagnosed with COVID-19. Diabetes patients should focus on a healthy…

12 Jun

Hike on the price of Petrol by 57 / litre

editor0 CommentsBusinessBusiness, Coronavirus, Covid-19, Fuel

Petrol price gets hiked by 57 paise per litre and diesel by 59 paise per litre as oil companies adjusted retail rates - the sixth straight day of increase in rates since oil firms adjusted their rates.Petrol price in Delhi was hiked to Rs 74.57 per litre from Rs 74, while diesel rates were increased to Rs 72.81 a litre from Rs 72.22, according to a price notification of state oil marketing companies.Rates have been increased across the country and vary in each state depending on the local sales tax or value added tax.This is the sixth consecutive daily increase in rates since oil…

12 Jun

Holding the IPL Will Lift the Mood of the Country During the Pandemic: BCCI Treasurer Dhumal

editor0 CommentsEntertainment, SportsCoronavirus, Covid-19, Cricket, INDIA, IPL, Ms Dhoni, Virat Kholi

BCCI treasurer Arun Dhumal has said the the Indian Premier League is not just about entertainment, but also about economics as because there are number of lives that depend on it.Dhumal said holding the IPL 2020 will 'lift the mood' of the country during the COVID-19 pandemic. He added that the BCCI would find it difficult to sustain cricketing activities in the country without the tournament.He says , "Some people say that BCCI is just bothered about IPL for the money involved and criticise us, but no one is putting their focus on the economics part of it. It’s not…

12 Jun

Johnson & Johnson to start trials of the vaccine in July

editor0 CommentsHealthCovid-19, Johnson, London

London: Johnson & Johnson said it would start human trials of its potential COVID-19 vaccine in the second half of July, two months earlier than planned, as drugmakers race to develop a shot for the deadly respiratory disease. There are currently no approved treatments or vaccines for COVID-19, the illness caused by the new coronavirus that has killed more than 400,000 people globally. J&J's study will test the vaccine against a placebo and assess the shot's safety and immune response in 1,045 healthy people aged 18 to 55 years, as well as those 65 years and older. The trial will…

11 Jun

Mumbai experience it’s highest one day spike of cases

editor0 CommentsNorth EastCorona, Coronavirus, Covid-19, ECONOMY, Lockdown, Maharastra

On Wednesday, Maharastra as well as mumbai experienced a highest 24 hours toll. Only after a week of the first phase of 'mission begin again' started the death rate was highest in a day. The state saw its highest single-day rise in cases (3,254) ,the previous highest toll was on June 5 (139 cases).The city in total has more positive cases (52,667) than the cases of Wuhan (50,333) the epicentre of corona virus outbreak. Mumbai city, which recorded a staggering 1,595 of these new cases to post its highest day-surge as well, breached the 20,000-case mark to rise to 20,150…

09 Jun

China may come with emergency vaccine withing months for Covid-19

editor0 CommentsHealthChina, Covid-19, Vaccine

Chinas top respiratory experts have claimed that the country may get Covid-19 vaccine for emergency use within the month. Dr Zhong Nanshan said during a live event with China’s search engine Baidu on Saturday that a coronavirus vaccine could be available as early as this autumn. Dr Antony Fauci, the head of the US National Institute of Allergy and Infectious Diseases, made similar comments, saying that we might have a COVID-19 vaccine by the end of this year, even before the end of clinical trials. WHO says more than 120 COVID-19 vaccines are being developed across the world, with 10…